Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Debt / NOTE 3.000%12/0
-
Market price (% of par)
-
105.45%
-
Total 13F principal
-
$57,788,683
-
Principal change
-
-$15,580,829
-
Total reported market value
-
$60,888,015
-
Number of holders
-
22
-
Value change
-
-$16,507,476
-
Number of buys
-
5
-
Number of sells
-
6
Institutional Holders of ANI PHARMACEUTICALS INC - NOTE 3.000%12/0 as of Q2 2017
As of 30 Jun 2017,
ANI PHARMACEUTICALS INC - NOTE 3.000%12/0 was held by
22 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$57,788,683
in principal (par value) of the bond.
The largest 10 bondholders included
FMR LLC, DLD Asset Management, LP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, PERCEPTIVE ADVISORS LLC, Jefferies Group LLC, Allianz Asset Management GmbH, CAMDEN ASSET MANAGEMENT L P /CA, GABELLI FUNDS LLC, PALISADE CAPITAL MANAGEMENT LLC/NJ, and Worth Venture Partners, LLC.
This page lists
22
institutional bondholders reporting positions
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.